EUVIMEDEUVIMED entdecken
Crossref

circPLEKHM1 promotes tumor growth and metastasis through enhancing FXR1-mediated protein translation in PDAC

Yang Yang, Zhang Li, Lanyang Gao, Yue Ming, Tingting Zhang, Zixia Ye, Wenrong Liu, Qunli Xiong, Xiaoming Xu, Fuyan Xu, Jiawei Guo, Jiao Li und 3 weitere

Cancer Letters · 2026-06 · 647 · 218414

DOI: 10.1016/j.canlet.2026.218414 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-06. Verfasst von Yang Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, RNA, Circular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province, Sichuan University, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circular RNAs (circRNAs) are increasingly recognized as pivotal regulators of cancer development, yet their functional roles in pancreatic ductal adenocarcinoma (PDAC) remain largely elusive. Here, we identify circPLEKHM1 as a significantly upregulated circRNA in PDAC tumors, with elevated expression strongly correlated with poor patient prognosis. Functional in vitro and in vivo analyses establish an oncogenic role for circPLEKHM1, demonstrating that its overexpression promotes tumor growth and metastasis, while its knockdown exerts suppressive effects. Mechanistically, circPLEKHM1 directly interacts with the RNA-binding protein FXR1, thereby preventing TRIM56-mediated proteasomal degradation of FXR1 and enhancing global protein synthesis. Notably, serum levels of circPLEKHM1 are significantly elevated in PDAC patients compared to healthy controls and individuals with other pancreatic conditions. Importantly, combining circPLEKHM1 with CA19-9 substantially improves diagnostic accuracy of PDAC detection. Collectively, these findings delineate circPLEKHM1 as a critical driver of PDAC progression and highlight its promise as robust liquid biopsy biomarker for PDAC diagnosis and prognosis assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Binding ProteinsCarcinoma, Pancreatic DuctalPancreatic NeoplasmsRNA, CircularHumansAnimalsCell ProliferationGene Expression Regulation, NeoplasticCell Line, TumorMicePrognosisBiomarkers, TumorProtein BiosynthesisMaleFemale

Stichwörter der Autor:innen

FXR1Pancreatic ductal adenocarcinomaProtein translationcircPLEKHM1

Substanzen

RNA-Binding ProteinsFXR1 protein, humanRNA, CircularBiomarkers, Tumor

Autor:innen und Institutionen

  • Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Center for Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China; Schoo…
  • Center for Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Center for Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China. Elect…
  • Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: newzhuqing1972@163.com.

Förderung

  • Natural Science Foundation of Sichuan Province
  • Sichuan University
  • West China Hospital, Sichuan University
  • National Natural Science Foundation of China

Zitieren

APA

Yang, Y., Li, Z., Gao, L., Ming, Y., Zhang, T., Ye, Z., Liu, W., Xiong, Q., Xu, X., Xu, F., Guo, J., Li, J., Yang, X., Peng, Y., & Zhu, Q. (2026). circPLEKHM1 promotes tumor growth and metastasis through enhancing FXR1-mediated protein translation in PDAC. Cancer Letters, 647, 218414. https://doi.org/10.1016/j.canlet.2026.218414

Vancouver

Yang Y, Li Z, Gao L, Ming Y, Zhang T, Ye Z, et al. circPLEKHM1 promotes tumor growth and metastasis through enhancing FXR1-mediated protein translation in PDAC. Cancer Letters. 2026;647:218414. doi:10.1016/j.canlet.2026.218414

BibTeX
@article{Yang2026,
  author = {Yang, Yang and Li, Zhang and Gao, Lanyang and Ming, Yue and Zhang, Tingting and Ye, Zixia and Liu, Wenrong and Xiong, Qunli and Xu, Xiaoming and Xu, Fuyan and Guo, Jiawei and Li, Jiao and Yang, Xiaojuan and Peng, Yong and Zhu, Qing},
  title = {circPLEKHM1 promotes tumor growth and metastasis through enhancing FXR1-mediated protein translation in PDAC},
  journal = {Cancer Letters},
  year = {2026},
  volume = {647},
  pages = {218414},
  doi = {10.1016/j.canlet.2026.218414}
}
Kostenlos starten →